An Overview of Oncotarget Peer-Reviewed Medical Journal

According to Impact Journals, Oncotarget refers to a multidisciplinary journal with free access; it publishes various papers on a weekly basis. The journal has a mission of ensuring that scientific results are available widely and rapidly. It also aims to ensure that exceptional discoveries are shared quickly. The journal aims at eliminating the borders that exist between specialties and provide links to the different biomedical science fields. It is under the leadership of prominent scientists who aim at helping various researchers to contribute to progress in science.

Impact Factor and Rank

Oncotarget ranks among the top medical journals in terms of the total documents published in Oncology. It is the highest ranking medical journal in the field of oncology. In the year 2015/2016, the journal had an impact factor (IF) of 5.008 and a total of 10452 cites. The medical journal was launched in 2010 and has managed to publish over 370 papers on topics related to oxygen.

Oncotarget Editors

Dove Press recalled that Oncotarget, there is an existing editorial board and two editors-in-chief. The two are Andrei V. Gudkov and Mikhail V, Blagosklonny. Andrei V. Gudkov, PhD., DSci, Professor is based at Roswell Park Cancer Institute as the senior vice president.

He has degrees in molecular biology and experimental oncology from Russia (Moscow State University and National Cancer Institute respectively). His areas of research interests include gene discovery, drug discovery and molecular targets necessary for cancer treatment.

Mikhail V. Blagosklonny, M.D., PhD., Professor, is also based at the Roswell Park Cancer Institute, Buffalo, NY. He is an author of more than 200 articles that have been published in peer-reviewed journals. He is an associate editor of Cell Death Differ, Cancer Res, Autophagy, Cancer Biol Ther, Am J pathology, Int J Cancer, PLOS ONE and the Cell Cycle editor-in-chief.

His research interest areas include molecular and cellular biology, clinical investigations, cell cycle, signal transduction, anticancer therapeutics and cellular senescence.

He is emphasizing on translating basic science into new strategies to fight cancer. In the recent past, Dr. Blagosklonny has extended his studies to signal transduction pathways from cancer and turned his focus on aging. This has revealed some potential targets for slowing down age-related diseases and aging.

E-cigarettes causing damage to gum tissues

According to a study published on Oncotarget, there are suggestions that electronic cigarettes are causing damages to the gum tissues. The study was conducted at UR School of Medicine and Dentistry, led by a professor of Environmental Medicine, Irfan Rahmann, Ph.D. It is the first scientific study on e-cigarettes causing detrimental effects on oral health on molecular and cellular levels.